Mobilising the alumni of a Master of Public Health degree to build research and development capacity in low- and middle-income settings: The Peoples-uni

Autor Heller, Richard F, Machingura, Pasipanodya I, Musa, Baba M, Sengupta, Paramita, Myles, Puja
Vydáno v Health Res Policy Syst (2015)

Challenges and prospects of snake antivenom supply in sub-Saharan Africa

Autor Habib, Abdulrazaq G., Musa, Baba M., Iliyasu, Garba, Hamza, Muhammad, Kuznik, Andreas, Chippaux, Jean-Philippe
Vydáno v PLoS Negl Trop Dis (2020)

HIV treatment and monitoring patterns in routine practice: a multi-country retrospective chart review of patient care

Autor Musa, Baba M, Ibekwe, Everistus, Mwale, Stanley, Eurien, Daniel, Oldenburg, Catherine, Chung, Gary, Heller, Richard F
Vydáno v F1000Res (2019)

Cost-effectiveness of expanding childhood routine immunization against Neisseria meningitidis serogroups C, W and Y with a quadrivalent conjugate vaccine in the African meningitis...

Autor Kuznik, Andreas, Iliyasu, Garba, Lamorde, Mohammed, Mahmud, Mustapha, Musa, Baba M., Nashabaru, Ibrahim, Obaro, Stephen, Mohammed, Idris, Habib, Abdulrazaq G.
Vydáno v PLoS One (2017)

The V-BRCH Project: building clinical trial research capacity for HIV and noncommunicable diseases in Nigeria

Autor Aliyu, Muktar H., Sani, Mahmoud U., Ingles, Donna J., Tsiga-Ahmed, Fatimah I., Musa, Baba M., Audet, Carolyn M., Wester, C. William
Vydáno v Health Res Policy Syst (2021)

Prevalence and Risk Factors for Diabetes Mellitus in Nigeria: A Systematic Review and Meta-Analysis

Autor Uloko, Andrew E., Musa, Baba M., Ramalan, Mansur A., Gezawa, Ibrahim D., Puepet, Fabian H., Uloko, Ayekame T., Borodo, Musa M., Sada, Kabiru B.
Vydáno v Diabetes Ther (2018)

Sex disparities in outcomes among adults on long-term antiretroviral treatment in northern Nigeria

Autor Musa, Baba M., Garbati, Musa A., Nashabaru, Ibrahim M., Yusuf, Shehu M., Nalado, Aisha M., Ibrahim, Daiyabu A., Simmons, Melynda N., Aliyu, Muktar H.
Vydáno v Int Health (2017)

Optimal management of HIV- positive adults at risk for kidney disease in Nigeria (Renal Risk Reduction “R3” Trial): protocol and study design

Autor Aliyu, Muktar H., Wudil, Usman J., Ingles, Donna J., Shepherd, Bryan E., Gong, Wu, Musa, Baba M., Muhammad, Hamza, Sani, Mahmoud U., Abdu, Aliyu, Nalado, Aisha M., Atanda, Akinfenwa, Ahonkhai, Aima A., Ikizler, Talat A., Winkler, Cheryl A., Kopp, Jeffrey B., Kimmel, Paul L., Wester, C. William
Vydáno v Trials (2019)